Market Cap : 323.68 M | Enterprise Value : 302.43 M | PE Ratio : At Loss | PB Ratio : 9.73 |
---|
NAS:TGAN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:TGAN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Transphorm's average Accounts Receivable for the three months ended in Mar. 2022 was $2.52 Mil. Transphorm's Revenue for the three months ended in Mar. 2022 was $4.93 Mil. Hence, Transphorm's Days Sales Outstanding for the three months ended in Mar. 2022 was 46.74.
The historical rank and industry rank for Transphorm's Days Sales Outstanding or its related term are showing as below:
During the past 3 years, Transphorm's highest Days Sales Outstanding was 31.86. The lowest was 21.68. And the median was 24.93.
TGAN's Days Sales Outstanding is ranked better thanTransphorm's Days Sales Outstanding increased from Mar. 2021 (46.32) to Mar. 2022 (46.74).
The historical data trend for Transphorm's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Semiconductor Equipment & Materials subindustry, Transphorm's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Semiconductors industry and Technology sector, Transphorm's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Transphorm's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Accounts Receivable can be measured by Days Sales Outstanding.
Transphorm's Days Sales Outstanding for the fiscal year that ended in Mar. 2022 is calculated as
Days Sales Outstanding (A: Mar. 2022 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Dec. 2020 ) | + | Accounts Receivable (A: Mar. 2022 )) | / | count ) | / | Revenue (A: Mar. 2022 ) | * | Days in Period |
= | ( (0.844 | + | 2.558) | / | 2 ) | / | 24.05 | * | 365 |
= | 1.701 | / | 24.05 | * | 365 | ||||
= | 25.82 |
Transphorm's Days Sales Outstanding for the quarter that ended in Mar. 2022 is calculated as:
Days Sales Outstanding (Q: Mar. 2022 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Dec. 2021 ) | + | Accounts Receivable (A: Mar. 2022 )) | / | count ) | / | Revenue (A: Mar. 2022 ) | * | Days in Period |
= | ( (2.489 | + | 2.558) | / | 2 ) | / | 4.927 | * | 365 / 4 |
= | 2.5235 | / | 4.927 | * | 365 / 4 | ||||
= | 46.74 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Thank you for viewing the detailed overview of Transphorm's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Kkr Group Co. Inc. | 10 percent owner | C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 30 HUDSON YARDS NEW YORK NY 10001 |
Moreland Cynthia J | director | 215 MOFFETT PARK DRIVE SUNNYVALE CA 94089 |
Smales Kelly | director | 75 CASTILIAN DRIVE GOLETA CA 93117 |
Mcfarland Katharina G. | director | 4803 STONECROFT BOULEVARD CHANTILLY VA 20151 |
Humphreys Michael Julian | director | 75 CASTILIAN DRIVE GOLETA CA 93117 |
Parikh Primit | officer: Chief Operating Officer | 75 CASTILIAN DRIVE GOLETA CA 93117 |
Kravis Henry R | 10 percent owner | C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 30 HUDSON YARDS NEW YORK NY 10001 |
Roberts George R | 10 percent owner | C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 2800 SAND HILL ROAD MENLO PARK CA 94025 |
Kkr & Co. Inc. | 10 percent owner | 30 HUDSON YARDS NEW YORK NY 10001 |
Kkr Phorm Investors Gp Llc | 10 percent owner | C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 30 HUDSON YARDS NEW YORK NY 10001 |
Kkr Phorm Investors L.p. | 10 percent owner | C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 30 HUDSON YARDS NEW YORK NY 10001 |
Wingtech Technology Co. Ltd. | 10 percent owner | 4F-6F, BUILDING 4 OF JUXIN YUAN, NO. 188 PINGFU ROAD, XUHUI DISTRICT SHANGHAI F4 200231 |
Nexperia B.v. | 10 percent owner | JONKERBOSPLEIN 52 AB NIJMEGEN P7 6534 |
Yatagawa Eiji | director | 75 CASTILIAN DRIVE GOLETA CA 93117 |
Mcaulay Cameron | officer: Chief Financial Officer | 75 CASTILIAN DRIVE GOLETA CA 93117 |
From GuruFocus
Other Sources
By Zacks 2021-12-10
By Zacks 2021-12-09
By Seekingalpha 2021-11-13
By Seekingalpha 2021-05-18
By Seekingalpha 2022-02-09
By Seekingalpha 2021-01-15
By Zacks 2022-02-09
By Seekingalpha 2022-02-09